Sep 12, 2016 11:55 am UTC| Business
DENVER, Sept. 12, 2016 -- PDC Energy, Inc. (“PDC” or the “Company”) (Nasdaq:PDCE) today announced the underwriters in its recent public offerings of common stock (the “common stock offering”) and convertible senior...
Inovalon and MDLIVE Bring Real-Time Advanced Analytics to Telemedicine Marketplace
Sep 12, 2016 11:55 am UTC| Business
BOWIE, Md., Sept. 12, 2016 -- Inovalon (NASDAQ:INOV), a leading technology company providing advanced, cloud-based analytics and data-driven intervention platforms to the healthcare industry, today announced a...
Sep 12, 2016 11:47 am UTC| Business
Sarasota, FL, Sept. 12, 2016 -- Zion Research has published a new report titled “PVC Market (Rigid PVC And Flexible PVC) by Application ( Pipes Fittings, Wires Cables, Films Sheets, Bottles and Others) For...
Pluristem Provides Fiscal Year 2016 Corporate and Financial Highlights
Sep 12, 2016 11:45 am UTC| Business
Executing an efficient commercialization strategy with three planned late stage pivotal trialsInnovative regulatory pathway clearances including EU adaptive pathway and Japanese accelerated pathway for regenerative...
Dermira Acquires Option to License Exclusive Rights for up to Three Early-Stage Programs from Takeda
Sep 12, 2016 11:30 am UTC| Business
MENLO PARK, Calif., Sept. 12, 2016 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to identifying, developing and commercializing innovative, differentiated therapies to improve the lives of...
Geron Provides Update on Imetelstat Trials Being Conducted by Janssen
Sep 12, 2016 11:30 am UTC| Business
MENLO PARK, Calif., Sept. 12, 2016 -- Geron Corporation (Nasdaq:GERN) today provided updates on the clinical trials being conducted by Janssen Research Development, LLC, of the telomerase inhibitor imetelstat. Planned...
Amicus Therapeutics to Present at Bank of America Merrill Lynch Global Healthcare Conference 2016
Sep 12, 2016 11:30 am UTC| Business
CRANBURY, N.J., Sept. 12, 2016 -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that Chip Baird, Chief Financial Officer,...